Machida, Japan

Masayuki Mitsuka

This inventor holds 1 USPTO granted patent. Top assignee: Mitsubishi Kasei Corporation. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masayuki Mitsuka. Retrieved from https://idiyas.com/inventor/masayuki-mitsuka-lsti3b5y

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Masayuki Mitsuka: Pharmaceutical Chemistry Inventor

Introduction

Masayuki Mitsuka is an inventor associated with Machida, Japan, and Mitsubishi Kasei Corporation. His patent work includes a pharmaceutical invention aimed at addressing elevated blood lipids.

Latest Patents

Mitsuka is credited with 1 patent, titled “Pyrrolecarboxylic Acid Derivatives.” The patent describes pyrrolecarboxylic acid derivatives and their pharmaceutically acceptable salts. The compounds are presented as potentially useful for reducing serum triglyceride or cholesterol levels and as active ingredients in pharmaceutical compositions for treating hyperlipemia and arteriosclerosis.

Career Highlights

Mitsuka’s documented patent contribution focuses on medicinal chemistry and compounds intended for therapeutic use. His work is associated with Mitsubishi Kasei Corporation.

Collaborations

Mitsuka’s listed coworkers include Shinya Inoue and Tadashi Shirasaka.

Conclusion

Masayuki Mitsuka’s patent record highlights a pharmaceutical innovation involving pyrrolecarboxylic acid derivatives proposed for managing elevated blood lipids and related conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…